Christopher Thomas Giordano is CEO of TENAX THERAPEUTICS, INC.. Currently has a direct ownership of 2,605 shares of TENX, which is worth approximately $18,495. The most recent transaction as insider was on Nov 20, 2025, when has been sold 538 shares (Common Stock) at a price of $7.59 per share, resulting in proceeds of $4,083. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.61K
n/a 3M change
n/a 12M change
Total Value Held $18,495

Christopher Thomas Giordano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2025
BUY
Open market or private purchase
$4,083 $7.59 p/Share
538 Added 17.12%
2,605 Common Stock
Nov 19 2025
BUY
Open market or private purchase
$3,417 $7.51 p/Share
455 Added 18.04%
2,067 Common Stock
Nov 18 2025
BUY
Open market or private purchase
$12,493 $7.75 p/Share
1,612 Added 50.0%
1,612 Common Stock
CTG

Christopher Thomas Giordano

CEO
Morrisville, NC

Track Institutional and Insider Activities on TENX

Follow TENAX THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TENX shares.

Notify only if

Insider Trading

Get notified when an Tenax Therapeutics, Inc. insider buys or sells TENX shares.

Notify only if

News

Receive news related to TENAX THERAPEUTICS, INC.

Track Activities on TENX